What Is Ocugen, Inc. (OCGN) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Ocugen, Inc.'s intrinsic value is estimated at $0.42, suggesting the stock is overvalued at its current price of $1.43. With 7 out of 8 models flagging downside (-70.8% average return), the market may be pricing in unsustainable growth. Notably, PWERM sees the most upside at +2.2% (fair value: $1.46), while First Chicago is the most conservative at -97.8% ($0.03). The spread between these extremes — +100.0% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About OCGN?
8 of 13 models are currently active for OCGN. Of these, 1 model suggests upside while 7 models suggest overvaluation. The Bayesian DCF estimates OCGN's intrinsic value at $0.25, implying -82.7% downside from the current price. See which stocks rank higher →
How Does OCGN Rank in Biological Products, (No Diagnostic Substances)?
Among 145 Biological Products, (No Diagnostic Substances) stocks, OCGN ranks #26 by Quality of Company score. CirclFi's QOC score of 6.6/10 evaluates 32 fundamental signals. A score of 6.6 indicates above-average quality.
See all Most Undervalued Biological Products, (No Diagnostic Substances) Stocks →
Ocugen, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is OCGN a Value Trap?
CirclFi's Value Trap algorithm assigns OCGN a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
8 of 13 models are active for Ocugen, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Ocugen, Inc.'s fundamental quality profile registers 6.6/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +100.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every OCGN valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across OCGN's 8 active models, average confidence is 21%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad